High resolution combined molecular and structural optical imaging of colorectal cancer in a xenograft mouse model

Fabio Feroldi, Mariska Verlaan, Helene Knaus, Valentina Davidoiu, Danielle J. Vugts, Guus A.M.S. Van Dongen, Carla F.M. Molthoff, Johannes F. De Boer

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

With the emergence of immunotherapies for cancer treatment, there is a rising clinical need to visualize the tumor microenvironment (TME) non-invasively in detail, which could be crucial to predict the efficacy of therapy. Nuclear imaging techniques enable whole-body imaging but lack the required spatial resolution. Conversely, near-infrared immunofluorescence (immuno-NIRF) is able to reveal tumor cells and/or other cell subsets in the TME by targeting the expression of a specific membrane receptor with fluorescently labeled monoclonal antibodies (mAb). Optical coherence tomography (OCT) provides three-dimensional morphological imaging of tissues without exogenous contrast agents. The combination of the two allows molecular and structural contrast at a resolution of ~15 µm, allowing for the specific location of a cell-type target with immuno-NIRF as well as revealing the three-dimensional architectural context with OCT. For the first time, combined immuno-NIRF and OCT of a tumor is demonstrated in situ in a xenograft mouse model of human colorectal cancer, targeted by a clinically-safe fluorescent mAb, revealing unprecedented details of the TME. A handheld scanner for ex vivo examination and an endoscope designed for imaging bronchioles in vivo are presented. This technique promises to complement nuclear imaging for diagnosing cancer invasiveness, precisely determining tumor margins, and studying the biodistribution of newly developed antibodies in high detail.

Original languageEnglish
Article number#346860
Pages (from-to)6186-6204
Number of pages19
JournalBiomedical Optics Express
Volume9
Issue number12
DOIs
Publication statusPublished - 1 Dec 2018

Fingerprint

Optical Imaging
Heterografts
mice
Colorectal Neoplasms
tumors
cancer
Tumor Microenvironment
Optical Coherence Tomography
high resolution
antibodies
Neoplasms
tomography
Monoclonal Antibodies
Bronchioles
Whole Body Imaging
Three-Dimensional Imaging
Endoscopes
endoscopes
Immunotherapy
Contrast Media

Keywords

  • Image quality
  • Imaging techniques
  • Magnetic resonance imaging
  • Optical imaging
  • Real time imaging
  • Three dimensional imaging

Cite this

Feroldi, Fabio ; Verlaan, Mariska ; Knaus, Helene ; Davidoiu, Valentina ; Vugts, Danielle J. ; Van Dongen, Guus A.M.S. ; Molthoff, Carla F.M. ; De Boer, Johannes F. / High resolution combined molecular and structural optical imaging of colorectal cancer in a xenograft mouse model. In: Biomedical Optics Express. 2018 ; Vol. 9, No. 12. pp. 6186-6204.
@article{3a4a0e74f9324e3eaba7382fc59cb085,
title = "High resolution combined molecular and structural optical imaging of colorectal cancer in a xenograft mouse model",
abstract = "With the emergence of immunotherapies for cancer treatment, there is a rising clinical need to visualize the tumor microenvironment (TME) non-invasively in detail, which could be crucial to predict the efficacy of therapy. Nuclear imaging techniques enable whole-body imaging but lack the required spatial resolution. Conversely, near-infrared immunofluorescence (immuno-NIRF) is able to reveal tumor cells and/or other cell subsets in the TME by targeting the expression of a specific membrane receptor with fluorescently labeled monoclonal antibodies (mAb). Optical coherence tomography (OCT) provides three-dimensional morphological imaging of tissues without exogenous contrast agents. The combination of the two allows molecular and structural contrast at a resolution of ~15 µm, allowing for the specific location of a cell-type target with immuno-NIRF as well as revealing the three-dimensional architectural context with OCT. For the first time, combined immuno-NIRF and OCT of a tumor is demonstrated in situ in a xenograft mouse model of human colorectal cancer, targeted by a clinically-safe fluorescent mAb, revealing unprecedented details of the TME. A handheld scanner for ex vivo examination and an endoscope designed for imaging bronchioles in vivo are presented. This technique promises to complement nuclear imaging for diagnosing cancer invasiveness, precisely determining tumor margins, and studying the biodistribution of newly developed antibodies in high detail.",
keywords = "Image quality, Imaging techniques, Magnetic resonance imaging, Optical imaging, Real time imaging, Three dimensional imaging",
author = "Fabio Feroldi and Mariska Verlaan and Helene Knaus and Valentina Davidoiu and Vugts, {Danielle J.} and {Van Dongen}, {Guus A.M.S.} and Molthoff, {Carla F.M.} and {De Boer}, {Johannes F.}",
year = "2018",
month = "12",
day = "1",
doi = "10.1364/BOE.9.006186",
language = "English",
volume = "9",
pages = "6186--6204",
journal = "Biomedical Optics Express",
issn = "2156-7085",
publisher = "The Optical Society",
number = "12",

}

High resolution combined molecular and structural optical imaging of colorectal cancer in a xenograft mouse model. / Feroldi, Fabio; Verlaan, Mariska; Knaus, Helene; Davidoiu, Valentina; Vugts, Danielle J.; Van Dongen, Guus A.M.S.; Molthoff, Carla F.M.; De Boer, Johannes F.

In: Biomedical Optics Express, Vol. 9, No. 12, #346860, 01.12.2018, p. 6186-6204.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - High resolution combined molecular and structural optical imaging of colorectal cancer in a xenograft mouse model

AU - Feroldi, Fabio

AU - Verlaan, Mariska

AU - Knaus, Helene

AU - Davidoiu, Valentina

AU - Vugts, Danielle J.

AU - Van Dongen, Guus A.M.S.

AU - Molthoff, Carla F.M.

AU - De Boer, Johannes F.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - With the emergence of immunotherapies for cancer treatment, there is a rising clinical need to visualize the tumor microenvironment (TME) non-invasively in detail, which could be crucial to predict the efficacy of therapy. Nuclear imaging techniques enable whole-body imaging but lack the required spatial resolution. Conversely, near-infrared immunofluorescence (immuno-NIRF) is able to reveal tumor cells and/or other cell subsets in the TME by targeting the expression of a specific membrane receptor with fluorescently labeled monoclonal antibodies (mAb). Optical coherence tomography (OCT) provides three-dimensional morphological imaging of tissues without exogenous contrast agents. The combination of the two allows molecular and structural contrast at a resolution of ~15 µm, allowing for the specific location of a cell-type target with immuno-NIRF as well as revealing the three-dimensional architectural context with OCT. For the first time, combined immuno-NIRF and OCT of a tumor is demonstrated in situ in a xenograft mouse model of human colorectal cancer, targeted by a clinically-safe fluorescent mAb, revealing unprecedented details of the TME. A handheld scanner for ex vivo examination and an endoscope designed for imaging bronchioles in vivo are presented. This technique promises to complement nuclear imaging for diagnosing cancer invasiveness, precisely determining tumor margins, and studying the biodistribution of newly developed antibodies in high detail.

AB - With the emergence of immunotherapies for cancer treatment, there is a rising clinical need to visualize the tumor microenvironment (TME) non-invasively in detail, which could be crucial to predict the efficacy of therapy. Nuclear imaging techniques enable whole-body imaging but lack the required spatial resolution. Conversely, near-infrared immunofluorescence (immuno-NIRF) is able to reveal tumor cells and/or other cell subsets in the TME by targeting the expression of a specific membrane receptor with fluorescently labeled monoclonal antibodies (mAb). Optical coherence tomography (OCT) provides three-dimensional morphological imaging of tissues without exogenous contrast agents. The combination of the two allows molecular and structural contrast at a resolution of ~15 µm, allowing for the specific location of a cell-type target with immuno-NIRF as well as revealing the three-dimensional architectural context with OCT. For the first time, combined immuno-NIRF and OCT of a tumor is demonstrated in situ in a xenograft mouse model of human colorectal cancer, targeted by a clinically-safe fluorescent mAb, revealing unprecedented details of the TME. A handheld scanner for ex vivo examination and an endoscope designed for imaging bronchioles in vivo are presented. This technique promises to complement nuclear imaging for diagnosing cancer invasiveness, precisely determining tumor margins, and studying the biodistribution of newly developed antibodies in high detail.

KW - Image quality

KW - Imaging techniques

KW - Magnetic resonance imaging

KW - Optical imaging

KW - Real time imaging

KW - Three dimensional imaging

UR - http://www.scopus.com/inward/record.url?scp=85057839624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057839624&partnerID=8YFLogxK

U2 - 10.1364/BOE.9.006186

DO - 10.1364/BOE.9.006186

M3 - Article

VL - 9

SP - 6186

EP - 6204

JO - Biomedical Optics Express

JF - Biomedical Optics Express

SN - 2156-7085

IS - 12

M1 - #346860

ER -